Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis

Human Molecular Genetics

Volumn 9, Issue 11, 2000, Pages 1563-1566

  Brown, Matthew A ^a   Edwards, Sarah ^a   Hoyle, Emma ^a   Campbell, Sarah ^a   Laval, Steven ^a   Daly, Ann K ^f   Pile, Kevin D ^b   Calin, Andrei ^c   Ebringer, Alan ^d   Weeks, Daniel E ^e   Wordsworth, B Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEBRISOQUINE 4 HYDROXYLASE;

ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 22; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; RECURRENCE RISK;

EID: 0034235730     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.11.1563     Document Type: Article

References (30)

1. van der Linden, S., Valkenburg, H. and Cats, A. (1983) The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study. Br. J. Rheumatol., 22, 18-19.
2. Rubin, L.A., Amos, C.I., Wade, J.A., Martin, J.R., Bale, S.J., Little, A.H., Gladman, D.D., Bonney, G.E, Rubenstein, J.D. and Siminovitch, K.A. (1994) Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis Rheum., 37, 1212-1220.
3. Brown, M.A., Pile, K.D., Kennedy, L.G., Campbell, D., Andrew, L., March, R., Shatford, J.L., Weeks, D.E., Calin, A. and Wordsworth, B.P. (1998) A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum., 41, 588-595.
4. Brewerton, D.A., Hart, F.D., Nicholls, A., Caffrey, M., James, D.C. and Sturrock, R.D. (1973) Ankylosing spondylitis and HL-A 27. Lancet, 1, 904-907.
5. Schlosstein, L., Terasaki, P.I., Bluestone, R. and Pearson, C. (1973) High association of an HL-A antigen W27, with ankylosing spondylitis. N. Engl. J. Med., 288, 704-705.
6. Robinson, W.P., van d. L.S., Khan, M.A., Rentsch, H.U., Cats, A., Russell, A. and Thomson, G. (1989) HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum., 32, 1135-1141.
7. Brown, M.A., Pile, K.D., Kennedy, L.G., Calin, A., Darke, C., Bell, J., Wordsworth, B.P. and Cornelis, F. (1996) HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann. Rheum. Dis., 55, 268-270.
8. Brown, M.A. and Wordsworth, B.P. (1997) Predisposing factors to spondyloarthropathies. Curr. Opin. Rheumatol., 9, 308-314.
9. Brown, M.A., Kennedy, L.G., MacGregor, A.J., Darke, C., Duncan, E., Shatford, J.L., Taylor, A., Calin, A. and Wordsworth, P. (1997) Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum., 40, 1823-1828.
10. Brown, M.A., Laval, S.H., Brophy, S. and Calin, A. (2000) Recurrence risk studies in ankylosing spondylitis favour oligogenic epistatic disease model. Ann. Rheum. Dis., in press.
11. Beyeler, C., Armstrong, M., Bird, H.A., Idle, J.R. and Daly, A.K. (1996) Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Ann. Rheum. Dis., 55, 66-68.
12. Polymeropoulos, M., Rath, D., Xiao, H. and Merril, C. (1992) Dinucleotide repeat polymorphism at the human debrisoquine 4-hydroxylase (CYP2D) locus. Nucleic Acids Res., 19, 1961.
13. Daly, A.K., Brockmoller, J., Broly, F., Eichelbaum, M., Evans, W.E., Gonzalez, F.J., Huang, J.D., Idle, J.R., Ingelman, Sundberg, M. and Ishizaki, T. (1996) Nomenclature for human CYP2D6 alleles. Pharmacogenetics, 6, 193-201.
14. Daly, A.K., Armstrong, M., Monkman, S.C., Idle, M.E. and Idle, J.R. (1991) Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes. Pharmacogenetics, 1, 33-41.
15. Sachse, C., Brockmoller, J., Bauer, S. and Roots, I. (1997) Cytochrome P450 2D6 variants in a caucasian population: allele frequencies and phenotypic consequences. Am. J. Hum. Genet., 60, 284-295.
16. Lathrop, G.M. (1983) Estimating genotype relative risks. Tissue Antigens, 22, 160-166.
17. Clayton, D. (1999) A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am. J. Hum. Genet., 65, 1170-1177.
18. Bandmann, O., Vaughan, J., Holmans, P., Marsden, C.D. and Wood, N.W. (1997) Association of slow acetylator phenotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet, 350, 1136-1139.
19. McCann, S., Pond, S., James, K. and Le Couteur, D. (1997) The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis. J. Neurol. Sci., 153, 50-53.
20. Wolf, C.R., Dale Smith, C.A., Gough, A.C., Moss, J.E., Vallis, K.A., Howard, G., Carey, F.J., Mills, K., McNee, W., Carmichael, J. and Spurr, N.K. (1992) Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis, 13, 1035-1038.
21. May, D., Black, C., Olsen, N., Csuka, M., Tanner, S., Bellino, L., Porter, J., Wilkinson, G. and Branch, R. (1990) Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoin. Clin. Pharmacol. Ther., 48, 286-295.
22. Baer, A., McAllister, C., Wilkinson, G., Woosley, R. and Pincus, T. (1986) Altered distribution of debrisoquine oxidation phenotypes in patients with systemic lupus erythematosus. Arthritis Rheum., 29, 843-850.
23. Griem, P., Wulferink, M., Sachs, B., Gonzalez, J. and Gleichmann, E. (1998) Allergic and autoimmune reactions to xenobiotics: how do they arise. Immunol. Today, 19, 133-141.
24. Sieper, J. and Braun, J. (1995) Pathogenesis of spondyloarthropathies -persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum., 38, 1547-1554.
25. van der Linden, S., Valkenburg, H.A. and Cats, A. (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum., 27, 361-368.
26. Steen, V.M., Andreassen, O.A., Daly, A.K., Tefre, T., Borresen, A.L., Idle, J.R. and Gulbrandsen, A.K. (1995) Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics, 5, 215-223.
27. O'Connell, J.R. and Weeks, D.E. (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet., 63, 259-266.
28. Satsangi, J., Parkes, M., Louis, E., Hashimoto, L., Kato, N., Welsh, K., Terwilliger, J.D., Lathrop, G.M., Bell, J.I. and Jewell, D.P. (1996) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature Genet., 14, 199-202.
29. Kruglyak, L. and Lander, E.S. (1995) Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am. J. Hum. Genet., 57, 439-454.
30. Risch, N. and Merikangas, K. (1996) The future of genetic studies of complex human diseases. Science, 273, 1516-1517.